Bio-Techne (TECH) Revenue (2009 - 2026)

Bio-Techne has reported Revenue for 18 years, with the latest figure at $321.2 million in Q2 2026.

• On a quarterly basis, Revenue rose 1.33% year-over-year to $321.2 million in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 0.38% change from a year earlier, with the FY2026 full-year figure at $1.2 billion, changed 0.38% from the prior year.
• Revenue was $321.2 million for Q2 2026 at Bio-Techne, up from $311.4 million in the prior quarter.
• The five-year high for Revenue was $321.2 million in Q2 2026, with the low at $269.7 million in Q3 2022.
• Average Revenue over 5 years is $294.9 million, with a median of $295.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Revenue rose 19.23% in 2022, then fell 1.51% in 2026.
• Over 5 years, Revenue stood at $271.6 million in 2022, then rose by 0.37% to $272.6 million in 2023, then climbed by 8.96% to $297.0 million in 2024, then decreased by 0.39% to $295.9 million in 2025, then grew by 8.56% to $321.2 million in 2026.
• The last three Revenue figures came in at $321.2 million (Q2 2026), $311.4 million (Q1 2026), and $295.9 million (Q4 2025), per Business Quant data.